State Street Corp Hookipa Pharma Inc. Transaction History

State Street Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.59 - $1.04 $5,605 - $9,880	9,500 Added 5.93%	169,690 $100,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $0.91 $5,210 - $8,175	-8,984 Reduced 5.31%	160,190 $99,000
Q2 2023 Aug 14, 2023	BUY	$0.71 - $1.97 $18,720 - $51,942	26,367 Added 18.46%	169,174 $148,000
Q4 2022 Feb 14, 2023	SELL	$0.73 - $14.6 $23,274 - $465,491	-31,883 Reduced 18.25%	142,807 $115,000
Q3 2022 Nov 15, 2022	BUY	$1.27 - $15.0 $717 - $8,475	565 Added 0.32%	174,690 $234,000
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $338,363 - $587,684	-254,409 Reduced 59.37%	174,125 $284,000
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $122,291 - $244,583	97,057 Added 29.28%	428,534 $977,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $68,255 - $174,006	-29,294 Reduced 8.12%	331,477 $772,000
Q3 2021 Nov 15, 2021	BUY	$5.89 - $9.35 $204,730 - $324,996	34,759 Added 10.66%	360,771 $2.13 Million
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $1.18 Million - $2.52 Million	129,214 Added 65.66%	326,012 $2.99 Million
Q1 2021 May 17, 2021	SELL	$10.64 - $14.7 $32,228 - $44,526	-3,029 Reduced 1.52%	196,798 $2.65 Million
Q4 2020 Feb 16, 2021	SELL	$9.32 - $13.63 $9,133 - $13,357	-980 Reduced 0.49%	199,827 $2.22 Million
Q3 2020 Nov 10, 2020	BUY	$8.59 - $11.89 $69,450 - $96,130	8,085 Added 4.2%	200,807 $1.9 Million
Q2 2020 Aug 14, 2020	BUY	$7.23 - $12.1 $540,160 - $904,003	74,711 Added 63.31%	192,722 $2.24 Million
Q1 2020 May 11, 2020	BUY	$5.9 - $13.8 $696,264 - $1.63 Million	118,011 New	118,011 $974,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.